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First discovered inmaizebyBarbaraMcClintock in the1940s, transposable elements (TEs) areDNAsequences that in somecaseshave the
ability to move along chromosomes or “transpose” in the genome. This revolutionary finding was initially met with resistance by the
scientific community and viewed by some as heretical. A large body of knowledge has accumulated over the last 60 years on the biology of
TEs. Indeed, it is now known that TEs can generate genomic instability and reconfigure gene expression networks both in the germline
and somatic cells. This review highlights recent findings on the role of TEs in health and diseases of the CNS, which were presented at the
2013 Society forNeurosciencemeeting. Thework of the speakers in this symposium shows that TEs are expressed and active in the brain,
challenging thedogma thatneuronal genomesare static and revealing that theyare susceptible to somatic genomic alterations. Thesenew
findings on TE expression and function in the CNS have major implications for understanding the neuroplasticity of the brain, which
could hypothetically have a role in shaping individual behavior and contribute to vulnerability to disease.
Introduction
Almost half of mammalian genomes are comprised of a class of
repeat DNA sequences known as transposable elements (TEs)
(Lander et al., 2001), where some TEs have the ability tomobilize
and change locations in the genome. Other eukaryotes contain
substantial proportions of TEs, making TEs a general feature of
genomes across many organisms (Adams et al., 2000; Waterston
et al., 2002; Gibbs et al., 2004; Nellaker et al., 2012). Yet, their
roles in human health and disease and in genomic evolution are
not well defined. Once considered “junk” or “selfish” DNA, TEs
are now being appreciated for their specific functional roles in a
variety of biological phenomena that can be both beneficial
and pathological to the organism (Bie´mont, 2010). Barbara
McClintock, who is credited with the discovery of TEs, first pro-
posed two main functions: (1) insertional mutagens and (2)
“controlling elements” that regulate the expression of nearby
genes.McClintock’s findingswere notwell accepted at the time of
publication of her seminal work (McClintock, 1951). A large
body of knowledge has accumulated over the last 60 years on TE
biology (Britten and Kohne, 1968; Grimaldi and Singer, 1982;
Boeke et al., 1985; Daniels and Deininger, 1985; Kazazian et al.,
1988; Xiong and Eickbush, 1988b; Britten et al., 1989;Dombroski
et al., 1991; Batzer et al., 1996; Moran et al., 1999). For example,
Kazazian et al. (1988) discovered that hemophilia A resulted from
a de novo insertion of a TE. This study was one of the first to
demonstrate that a TE insertion in the human genome caused
disease (Kazazian et al., 1988). However, a new interest in the
function of TEs has resulted in part from large-scale genomic
projects, such as the ENCyclopedia Of DNA Elements
(ENCODE) and Functional Annotation of Mouse (FANTOM)
projects. These studies showed that TEs are active in a highly cell
type-specific manner and control their own cell-specific tran-
scription as well as the transcription of neighboring genes
(Faulkner et al., 2009; Djebali et al., 2012; Thurman et al., 2012).
Finally, the advent of next-generationwhole-genome sequencing
approaches has identified major structural variation resulting
from TE activity (Beck et al., 2010; Ewing and Kazazian, 2010;
Huang et al., 2010; Iskow et al., 2010).
There are two major classes of TEs, distinguished by their
mechanism of transposition (Levin and Moran, 2011). DNA
transposonsmove via a cut-and-paste mechanism and are gener-
ally thought to be extinct in higher eukaryotes. Therefore, DNA
transposonswill not be discussed further in this review.However,
RNA transposons (herein called retrotransposons or mobile ele-
ments) move via a copy-and-paste mechanism using RNA as an
intermediate. Retrotransposons, namely, Long-Interspersed Ele-
ments (LINE1s), are the only known active and autonomous
elements in the human genome (Beck et al., 2011). Other retro-
transposon families include: Short-INterspersed Elements
(SINEs), Alu and SVA elements. Retrotransposons with a long
terminal repeat (LTR), such as endogenous retroviruses (ERVs),
are also present in the human genome, but evidence has yet to be
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shown that ERVs have the ability to move (Moyes et al., 2007).
Retrotransposition-mediated events in mammals are not only
confined to germ cells, as once thought, but can produce somatic
alterations in the brain and cancer (Muotri et al., 2005; Baillie et
al., 2011; Solyom et al., 2012). That retrotransposons can gener-
ate neuronal somatic mosaics (Singer et al., 2010), creating ge-
netic heterogeneity across neurons in the same individual, has
wide-reaching implications for all areas of neuroscience (Muotri
et al., 2005; Baillie et al., 2011; Perrat et al., 2013).
This review focuses on the recent identification of CNS-
specific retrotransposons as generators of genetic heterogeneity,
their regulation and function, and their role in health and dis-
eases of the brain (Thomas et al., 2012).Many challenges remain,
but new technologies for retrotransposon capture sequencing
(Baillie et al., 2011) and single-cell TE analysis (Evrony et al.,
2012) are opening up novel areas for discovery. However, retro-
transposons may play a role in neurogenesis (Muotri et al., 2005;
Coufal et al., 2009; Muotri et al., 2010), aging (Li et al., 2013),
neurodegenerative diseases (Li et al., 2012), alcoholism (Pono-
marev et al., 2012), and post-traumatic stress disorder (PTSD)
(Ponomarev et al., 2010). The latest findings in these areas will be
presented in a symposium at the annual Society for Neuroscience
meeting in 2013.
Mobile elements, neuronal mosaicism, and evolution
Each cell in the body contains DNA, which instructs the cell and
tissues to perform specific functions through the transcription of
mRNAand translation of proteins. TheDNA sequencewithin the
nucleus has long been thought to be identical across different cell
types within an individual, with the exception of the gene rear-
rangements in the immune system and in some cancer cells. The
finding that L1 retrotransposons are active in somatic cells and
have structural and functional consequences in neuronal ge-
nomes challenges the dogma that neurons are genetically stable
entities (Muotri et al., 2005; Coufal et al., 2009; Baillie et al., 2011;
Evrony et al., 2012; Perrat et al., 2013). The consequences of L1
activity in neurons resulting in neuronal mosaicism are evident
throughout embryo development and in the adult brain (Thomas
et al., 2012). This novel mechanism may contribute to genomic
neuronal diversity across neurons in the same individual: the
“one human, multiple genomes” phenomenon that has been
demonstrated in a number of different cell types (Lupski, 2013).
These findings on somatic retrotransposition in the brain offer a
new paradigm to understand the unexplained variation seen in
many psychiatric disorders that has evaded detection by conven-
tionalmethods, such as genome-wide association studies (Mano-
lio et al., 2009). Perhaps more generally important is the role of
mobile elements in evolution, where they can be characterized
as having a constructive role in genomic innovation rather
than just being another random source of genetic variation
(Heard et al., 2010).
L1s are one of the most ancient and successful innovations in
eukaryotic genomes, comprising20% of mammalian genomes
(Lander et al., 2001; Waterston et al., 2002; Gibbs et al., 2004;
Nellaker et al., 2012). Active human L1s are6 kb long, harbor
an internal polymerase II promoter, and encode two open read-
ing frames (ORFs) (an RNA chaperone protein, ORF1, and an
endonuclease and reverse transcriptase protein, ORF2), usually
ending with a polyadenylic acid or short A-rich tail. They are the
only autonomous transposable element known in the present-
day human genome, encoding the essential machinery required
to move within the genome. Upon translation, the L1 RNA as-
sembles with its own encoded proteins (cis-preference) (Wei et
al., 2001; Dewannieux et al., 2003) and moves to the nucleus,
where an endonuclease makes a single-stranded nick and the
reverse transcriptase uses the nicked DNA to prime reverse tran-
scription from the 3 end of the L1 RNA. L1-encoded proteins
also provide the machinery to mobilize (in trans) nonautono-
mous retrotransposons (e.g., Alu and SVA elements) and other
mRNAs that generate processed pseudogenes (Esnault et al.,
2000;Wei et al., 2001; Kajikawa andOkada, 2002; Dewannieux et
al., 2003; Hancks et al., 2012; Raiz et al., 2012). Reverse transcrip-
tion frequently fails to proceed to the 5 end, resulting in mainly
truncated, nonfunctional de novo insertions. In addition, epige-
netic and post-transcriptional silencing mechanisms exist to re-
press mobilization in somatic cells (Whitelaw and Martin, 2001;
Slotkin and Martienssen, 2007; Chung et al., 2008; Czech et al.,
2008; Ghildiyal et al., 2008; Kawamura et al., 2008; Garcia-Perez
et al., 2010). However, there is evidence that some L1 insertions
are functional. Human L1s structurally resemble those present in
rodent and even invertebrate genomes, and a cultured cell retro-
transposition assay has revealed that human L1s can retrotrans-
pose in a variety of mammalian, nonhuman cell lines (Moran et
al., 1996; Coufal et al., 2009).
Based on reverse transcriptase phylogeny, L1 elements are
most closely related to the group II introns of mitochondria and
eubacteria (Xiong and Eickbush, 1990; Cavalier-Smith, 1991).
These studies revealed that the reverse transcriptase enzyme is
extremely old and that retroelements can be viewed as relics or
molecular fossils of the first primitive replication systems in the
progenote. The origin of retroelements possibly traces back to the
conversion of RNA-based systems, the “RNAWorld,” tomodern
“DNA-based” systems. Currentmodels suggest that thesemobile
introns of eubacteria were transmitted to eukaryotes during the
initial fusion of the eubacterial and archaebacterial genomes or
during the symbiosis that gave rise to the mitochondria, generat-
ing themodern-day spliceosomal introns (Zimmerly et al., 1995).
Further acquisition of an endonuclease enzyme and a promoter
sequence represented important steps in the evolution of L1 ret-
rotransposons, providing autonomy for L1s to insert into many
locations throughout the genome and provide themolecularma-
chinery for mobilization of nonautonomous elements.
The apparent lack of function of retroelements in the genome
has long puzzled scientists and inspired the concept of “junk
DNA” to illustrate the idea that such sequences are mere evolu-
tionary remnants (Ohno, 1972). However, the recognition that
retrotransposons can actively reshape the genome is slowly chal-
lenging this terminology.Moreover, themammalian genome has
suffered waves of transposon bombardment, but the constant,
single lineage of L1 history reveals that active, retrotransposition-
competent L1 sequences were never absent from mammals’ ge-
nomes during evolution, suggesting an inextricable link between
L1s and their hosts (Levin and Moran, 2011). The relationship
between transposons and their hosts is probably not entirely an-
tagonistic, as several host genes have a high degree of homology to
one ormore transposable elements. For example, the sequence of
paired box gene 6 (PAX6), a DNA-binding protein that regulates
transcription, is derived from a transposase (Feschotte, 2008). In
addition, the telomerase enzyme, responsible in most mammals
for replication of the ends of chromosomes, is derived from ret-
rotransposons (Nakamura and Cech, 1998). As described above,
accumulating recent evidence in the literature points to a somatic
function for L1 transcripts, involving cell proliferation, differen-
tiation, and embryo development, although it is unclear how
these different retrotransposons may be acting. Moreover, it is
difficult to determine why the genome would need so many cop-
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ies of retrotransposons and whether this expansion has any cor-
relation with retrotransposition itself. The lack of an “apparent”
cell function suggests that transposable elements are “selfish
DNA,” acting as parasites in the genome to propagate themselves
(Orgel and Crick, 1980). The restricted activity of retrotrans-
posons in germ or early embryonic cells apparently fits well with
this concept because new insertions will be passed to the next
generation. However, somatic insertions pose a conundrum be-
cause theywill not be transmitted to the next generation. Accord-
ing to the symbiotic theory, it is advantageous to any transposable
element to promote host mating, securing the propagation of the
“master” elements to the next generation. From this perspective,
it would not be surprising if advantageous insertional events in
the brain, resulting in a better (cultural and social) fitness of the
individual organism, also contributed to host mating. For exam-
ple, Barsoum et al. (2010) showed that a transposable element
promotes host sexual reproduction. This is the first empirical
evidence of an association between a transposable element and
sexual reproduction (Barsoum et al., 2010), which is congruent
with a theoretical model proposed by Hickey (1982). Such a
model requires the mechanism that allows retrotransposition in
somatic cells to be similar to themechanism existing in germ cells
(i.e., that the factors involved in L1 mobilization in germ cells be
related to the factors acting in the brain). Indeed, in silico data
reported similarities between human brain and testes gene ex-
pression patterns (Guo et al., 2003, 2005). It has been proposed
that the similarities in expression in human brain and testes may
have very important implications for human speciation (Wilda et
al., 2000; Graves, 2010). The emergence of new species during
evolution might be the result of coordinated changes in many
organ systems, and the organs associated with evolution would
share a common set of regulatory genes. Although it has been
proposed that genes in the Sox family in testes and brain share the
same genetic origins, it seems unlikely that all other factors in-
volved in L1 transcription would behave in the same way, con-
tributing to the obvious differences observed in these two tissues.
Although the role of transposable elements in human speciation
and the hypothesis that the brain and reproductive organs coor-
dinate this process are still highly speculative, the characteriza-
tion of factors involved in the L1 retrotransposition in germ and
brain cells will provide further insights into the evolution of these
two organs.
If new L1 insertions in the brain are not passed to future
generations, why would evolution conserve such amechanism in
the nervous system? Our hypothesis is that it is the propensity for
L1 mobilization, rather than its consequences, on which natural
selection may apply (Upton et al., 2011). Somatic retrotranspo-
sition may lead to the evolution of functional de novo regulatory
elements more rapidly than by random accumulation of point
mutations (Mukamel and Tanay, 2013), creating a greater poten-
tial for adaptation of beneficial genetic networks. As mentioned
above, epigenetic modifications, particularly DNA methylation
of CpG dinucletodies, are mechanisms used to suppress L1 mo-
bilization. These potentially heritable epigenetic modifications
may suppress deleterious L1 insertions, providing a buffer to
allow further adaptation of L1 regulatory elements for the benefit
of the host (Xie et al., 2013). This hypothesis is certainly specula-
tive but might gain support by studying our own species. The
human species has an enormous spectrum of phenotypic varia-
tion, despite being genetically quite homogeneous (Lander et al.,
2001; Witherspoon et al., 2007; Henn et al., 2012). It has been
proposed that a major portion of biological complexity in hu-
mans arises from regulation of the genome by the non-protein
coding regions (e.g., epigenetic modifications and noncoding
RNAs) (Carroll, 2008; Mattick et al., 2010). The diversity of be-
haviors, cultural practices, and languages that are not biologically
inherited but have biological origins may have been important to
control new resources or inhospitable territories. At the individ-
ual level, humans are also very diverse. Such variation can even be
found in genetically identical twins. Recent studies have pointed
to epigenetic variations during the life of monozygotic twins
(Fraga et al., 2005). However, the idea that epigenetic modifica-
tions underlie many of the cognitive and sociobehavioral traits in
humans is still highly speculative. The evolution of the CNS pro-
vided a notable selective advantage, as information about the
environment could be processed rapidly and would allow or-
ganisms to more readily meet the challenges of ever-changing
environmental conditions. Moreover, epigenetic modification
allowed the nongenetic transfer of information or transmission
of “culture” at an unprecedented magnitude (Jablonka and
Lamb, 2007). Such specialization is highly dependent on the cog-
nition levels acquired by the species, and cognitive levels are
directly linked to the complexity of the neuronal network. There-
fore, the advantages gained by retaining the mechanisms for so-
matic retrotransposition may outweigh the cost of a less plastic
nervous system.We think that L1 retrotranspositionmay be part
of a conserved core process responsible for generating genetic
variability within germ and neural genomes. That is, the core
molecular processes controlling L1 retrotransposition are con-
served across organs (e.g., brain and testis) but result in different
phenotypic cellular traits because of retrotransposition at varying
loci, a principle known as pleiotropy (Wagner and Zhang, 2011).
Such a process could evoke a facilitated, complex, nonrandom
phenotypical variation on which selection would act. Therefore,
transposable elements may play a constructive role in evolution
and organogensis, where transposable elements could be co-
opted by their host as cis-regulatory elements and direct novel
patterns of gene expression (Emera and Wagner, 2012; Wanich-
nopparat et al., 2013).
Techniques for mapping retrotransposons in the brain
The frequency, developmental timing, and functional conse-
quences of endogenous L1 retrotransposition in the mammalian
brain remain largely unclear. Until recently, experimental evi-
dence supporting neuronal L1 activity was primarily supplied by
(1) engineered L1 reporter assays, measuring mobilization of an
EGFP tagged L1 (L1-EGFP) in vitro and in vivo (Ostertag et al.,
2000; Muotri et al., 2005, 2009; Coufal et al., 2009), and (2) L1
copy number variation (CNV) assays based on TaqMan qPCR of
genomic DNA extracted from human tissue (Coufal et al., 2009).
These approaches enabled the laboratory of F.H.G. and others to
make the seminal observation that L1 activation occurs in neu-
ronal precursor cells and produces L1 CNV in the human body,
enriched in the brain (Muotri et al., 2005; Coufal et al., 2009).
Critically, in vivo 3D modeling using a transgenic L1-EGFP
mouse revealed few GFP-positive clusters1–2 cells, suggesting
that most L1 activity occurred late in neuronal differentiation
(Muotri et al., 2010). This viewwas reinforced by the finding that
mouse and human neuronal precursor cells deficient for the L1
promoter repressor MeCP2 exhibited higher L1-EGFP activity
and L1 CNV than wild-type controls (Muotri et al., 2010). To-
gether, these data highlighted a highly complex somatic genome
mosaic in the brain (Singer et al., 2010), driven by L1 and with an
apparent enrichment for the subgranular zone of the hippocam-
pus, an established neurogenic niche (Eriksson et al., 1998).
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Despite yielding intriguing and consistent data, several draw-
backs are apparent for the L1-EGFP and L1 CNV assays. For
instance, as an engineered system, epigenetic regulation of the
L1-EGFP system may not exactly recapitulate regulation of en-
dogenous L1s in vivo, potentially overstating their activity. Con-
versely, the addition of a 1.2 kb GFP reporter construct at the 3
end of a tagged L1 element (Ostertag et al., 2000) may understate
L1 activity in situations where L1 reverse transcription extends
for1.2 kb at a given integration site. Absolute quantification of
L1mobilization per cell using the L1CNVassay, an approach that
has indicated up to 80 somatic L1 copies per human neuron
(Coufal et al., 2009), is confounded by the need to perform a
plasmid “spike-in” as a reference control. It is also a possibility
that L1 reverse transcription occurs in cytoplasmic foci without
genomic integration. Thus, although these techniques provoked
the key hypothesis that L1 mobilization occurred in neuronal
precursor cells,more direct approaches, such as high-throughput
sequencing, were required to precisely establish how often L1
mobilized during neurogenesis and, just as importantly, to deter-
mine which loci contained new L1 insertions.
Genomic mapping of somatic L1 variants in the brain is
confounded by (1) high L1 copy number in genomic DNA
(500,000 L1 copies in the human reference sequence) and (2)
the projected rarity of each individual L1 insertion. One way to
overcome these issues is to perform targeted, deep sequencing of
L1 integration sites. For instance, retrotransposon capture se-
quencing (RC-seq), an L1 mapping strategy based on sequence
capture enrichment of L1 5 and 3 genomic junctions and ap-
plied to hippocampus and caudate samples from three individu-
als, reported several thousand somatic L1 insertions (Baillie et al.,
2011). These occurred primarily in hippocampus, a trend
strongly correlated with L1 CNV assay data obtained from the
same samples (Baillie et al., 2011). Other approaches developed
to study Drosophila transposable elements detected endogenous
retrotransposition in purified neurons, with whole-genome se-
quencing (Perrat et al., 2013) and in vivo with a gypsy-TRAP
reporter (Li et al., 2013), suggesting that a range of underexplored
methodological options may yet be made available to study L1
mobilization in “bulk” human tissue samples.
However, the recent invention of single-cell genomic analysis
techniques will likely prove decisive in counting somatic L1 in-
sertions in neurons. In a recent landmark publication, Evrony et
al. (2012) presented L1 mapping data from single neurons, using
whole-genome amplification followed by targeted L1 sequenc-
ing. A total of 300 single neurons from the caudate and cerebral
cortex were obtained from three normal individuals. Ninety-six
candidate somatic L1 insertions were identified. Most of these
candidates were deemed false positives after validation assays.
However, one candidate somatic L1 insertion was successfully
cloned. A full-length 6.1 kB L1 sequence was confirmed that con-
tained all the characteristics of a retrotransposon: a target site
duplication (TSD), a poly-A tail, and a 5 transduction sequence.
Four additional L1 insertions were validated by insertion site
PCR at their 3 end, but target site duplications could not be
identified. Crucially, this was the first report of a validated so-
matic L1 insertion presenting TSDs in a human neuron, perhaps
the best evidence presented thus far that L1 mobilization can
occur in the brain.
The L1 mobilization rate reported by Evrony et al. (2012),
perhaps as low as 1 in 300 neurons, contrasts with earlier calcu-
lations based on the L1 CNV assay (Coufal et al., 2009). It is,
however, important to note that Evrony et al. (2012) did not
evaluate hippocampal neurons, whereas other groups had previ-
ously reported major enrichment in this region (Coufal et al.,
2009; Baillie et al., 2011),making it difficult to determinewhether
the discrepancy in L1 mobilization frequency estimates is the
result of technical or brain regional differences. In addition, be-
cause brain samples in the studies of Baillie et al. (2011) and
Evrony et al. (2012) were obtained from different individuals,
biological variability could explain the discrepancies in L1 mobi-
lization rate. That is, there may be biological heterogeneity in the
rate of L1 mobilization across different populations of individu-
als. Further, because a range of environmental factors, including
stress (Ponomarev et al., 2010; Hunter et al., 2012), alcohol
(Ponomarev et al., 2012), and exercise (Muotri et al., 2009), can
alter retrotransposon expression, variation in environmental ex-
posures across individuals may contribute to the differences re-
ported in the two studies. In any case, it is important to note that
the adult human brain contains86 billion neurons (Azevedo et
al., 2009). Based on the lower estimate of 1 new L1 insertion per
300 neurons, an extrapolation suggests that nearly 300 million
distinct somatic L1 insertions would be found per brain. There-
fore, even if lower estimates of new L1 insertions are correct,
somatic retrotransposition could still potentially have a dramatic
effect on the function of neurons.
Although others have found brain-specific L1 insertions to be
enriched in genes involved in neurogenesis, evenwhen correction
for the unusual size of these genes was performed (Baillie et al.,
2011), it remains unclear whether these mutations alter the func-
tion of the affected neurons. Moreover, although the full-length
somatic L1 insertion found by Evrony et al. (2012) occurred in an
intron of IQCH, a gene expressed in the brain, it was not deter-
mined whether host gene expression was perturbed. Future ex-
periments guided by recent technical innovations are required to
corroborate and build upon the twomajor reports of L1mapping
in the human brain published to date (Baillie et al., 2011; Evrony
et al., 2012).
The transposon storm: from Barbara McClintock to
Lou Gehrig
Barbara McClintock’s dissociator and activator transposons ex-
plained unstable cellular inheritance of pigmentation patterns in
maize (McClintock, 1951, 1984). McClintock referred to these
transposons as “controlling elements” because theirmobilization
impacted the expression of nearby genes. Thus, even in Mc-
Clintock’s original work nearly 60 years ago, the potential for
transposons to shape phenotypic outcomes was apparent, chal-
lenging the prevailing view that transposons were mere selfish
DNA (Orgel and Crick, 1980). On the other hand, the unregu-
lated activation of transposons, as seen for example with dysgenic
crosses, reveals the powerful harmful impact of unregulated mo-
bile elements (Pignatelli and Mackay, 1989; Jensen et al., 1995,
1999; Malone and Hannon, 2009). Indeed, animals and plants
have evolved formidable surveillance mechanisms to detect and
eliminate expression of transposons both in germline and so-
matic cells (Ghildiyal and Zamore, 2009; Czech and Hannon,
2011). The discovery that some transposable elements are ac-
tively mobile in brain (Muotri et al., 2005, 2010; Coufal et al.,
2009; Baillie et al., 2011; Evrony et al., 2012; Perrat et al., 2013)
thus raises two potential possibilities. The first, discussed above,
is the notion that insertion of transposable elements may exert a
controlling influence on flanking genes, causing a functionally
relevant impact on the diversification of neuronal cell types or on
the function of differentiated neurons. At the same time, how-
ever, we must consider the potential detrimental impact of un-
regulated transposon expression.
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Transcripts from severalDrosophila retrotransposons, such as
R1 and R2 (which are LINE-like elements) and Gypsy (an LTR-
retrotransposon), become highly expressed in head tissue during
the course of normal aging (Li et al., 2013). In the case of Gypsy,
a monoclonal antibody against the third Orf, which encodes the
Env protein, also reveals a striking age-dependent accumulation
of Env-immunoreactive puncta throughout neuropil and the
“cortical” regions of the fly brain, which contain most of the
neuronal and glial somata. In addition, age-dependent expres-
sion of Gypsy is associated with accumulation of de novo trans-
position events in neurons. This association was revealed using a
“Gypsy-trap” reporter system in which a genomic hotspot for
Gypsy integrations was incorporated into a transgenic construct
such that insertions of Gypsy would inactivate expression of a
Gal80 repressor (Li et al., 2013). Gypsy insertions thus turns off
the repressor, allowing Gal4-mediated expression of a GFP
reporter. This Gypsy-trap reporter revealed an apparently sto-
chastic and sparse labeling of neurons that accumulated with
advancing age.
In broad strokes, the finding that certain retrotransposons are
active and even mobile in brain during aging is parsimonious
with the observed mobility of L1s during mammalian neurogen-
esis (Muotri et al., 2005; Baillie et al., 2011) and of a number of
transposable elements during Drosophila neurodevelopment
(Perrat et al., 2013). On the other hand, the age-dependent in-
crease in transposition in Drosophila brain that takes place after
development is almost certainly occurring in terminally differen-
tiated neurons because adult neurogenesis has not been seen in
Drosophila. Thus, the observed age-dependent activation is
mechanistically distinct from the transposition that normally oc-
curs during development and neurogenesis. And, in contrast
with the potential for a functionally relevant impact on normal
neurophysiology with transposition during neurogenesis, two
features of the age-dependent activation suggest detrimental con-
sequences. First is the fact that both R1 and R2, unlike most
LINE-like elements, exhibit target specificity in the genome. Both
of these elements target unique locations within the 28s subunit
of rRNA (Xiong and Eickbush, 1988a; Eickbush et al., 1997;Moss
et al., 2011). In the case of R2, almost all insertions occur at the
28 s target site. Thus, unlike LINE 1 elements in mammals, R1
and R2 seem less likely to produce genetic heterogeneity that
could functionally diversify neuronal physiology in a meaningful
way. Because insertion of either of these elements is sufficient to
inactivate the rRNA subunit, the accumulation of de novo insertions
of R1 or R2 during aging would seem likely to have detrimental
rather than beneficial consequences. A second observation that sug-
gests disruptive effects is the time course of transposon activation.
The expression of R1, R2, and Gypsy and the accumulation of de
novoGypsy insertions eachbegin in 2- to 4-week-old adults (Li et al.,
2013), which is relatively late in the life span ofDrosophila. Thus, the
time course of transposon activation in the adultDrosophila brain is
more consistent with an impact on age-related decline than on nor-
mal function.
However, there are cases where transposon activation inDro-
sophila is not purely antagonistic or detrimental to the organism.
For example, non-LTR retrotransposons have been recruited to
serve a telomerase function in Drosophila, which maintains
genomic integrity (Zhang and Rong, 2012). Nonetheless, trans-
poson activation in the germline has documented detrimental
consequences for a number of reasons, including genomic insta-
bility, accumulation of deleterious mutations, toxic accumula-
tion of protein or RNA products, and activation of DNA-damage
induced apoptosis (Tanda and Corces, 1991; Sheen et al., 1993;
Houle and Nuzhdin, 2004; Navarro et al., 2009). Two sets of
findings provide indirect evidence that age-dependent activation
of transposons in brain does indeed have a detrimental impact.
The first comes frommanipulations of the Chk2 signal that nor-
mally results in apoptosis afterDNAdamage and the second from
disruption ofDrosophila argonaute-2 (Chen et al., 2007; Klatten-
hoff et al., 2007; Chung et al., 2008; Czech et al., 2008; Ghildiyal et
al., 2008; Kawamura et al., 2008).
The negative consequences of DNA damage resulting from
transposon activation have been established in the germline. Par-
adoxically, blocking the DNA damage-induced signaling that
normally leads to apoptosis can in some situations ameliorate the
destructive effects of transposon activation in the germline. Dis-
ruption of Chk2-mediated signaling of DNA damage “tricks”
cells into staying alive and actually suppresses the sterility caused
by transposons (Chen et al., 2007; Klattenhoff et al., 2007). This
same “trick” appears to ameliorate some of the effects of age in
Drosophila, where disruption of the Chk2 ortholog in neurons is
sufficient to extend life span (Li et al., 2013). Although the con-
nection between the functional effects of disrupting Chk2 and
retrotransposons is indirect, it is tempting to speculate that trans-
poson activation contributes to age-dependent neurophysiolog-
ical decline in part by induction of DNA damage leading to
apoptosis.
A second line of evidence that is consistent with the interpre-
tation that age-dependent transposon activation in brain is
detrimental comes from manipulation of the Drosophila
argonaute-2 gene. Argonaute proteins are guided by small regu-
latory RNAs to silence transposons that contain complementary
sequences (Ghildiyal and Zamore, 2009; Czech and Hannon,
2011). In Drosophila, this cellular immunity against transposons
in germline versus somatic tissue relies on different argonaute
proteins that load distinct pools of small RNAs. Silencing of
transposons in somatic tissues, but not germline, requires the
Drosophila argonaute-2 gene (Chung et al., 2008; Czech et al.,
2008; Ghildiyal et al., 2008; Kawamura et al., 2008). Thus, muta-
tion of argonaute-2 in flies provides a means to unleash trans-
posons in somatic tissues independent of age. Such mutations
indeed lead to precocious expression of R1, R2, and Gypsy in
young brains to levels normally seen only in older animals (Li
et al., 2013). This expression is accompanied by rapid age-
dependentmemory impairment and shortened life span. Thus in
flies, transposon activation appears to accompany normal aging,
and precocious activation of these transposons correlates with
more rapid neurophysiological decline. Such functional studies
of transposon activation in mammalian brain during aging have
not been reported, but there are a few lines of evidence that mo-
bile elements may become actively expressed in patients with
several different neurodegenerative disorders and in animal
models of the disorders (Lathe and Harris, 2009; Jeong et al.,
2010;Muotri et al., 2010; Coufal et al., 2011; Douville et al., 2011;
Kaneko et al., 2011; Li et al., 2012; Tan et al., 2012). In the case of
amyotrophic lateral sclerosis (Lou Gehrig’s disease) and fronto-
temporal lobar degeneration, there is a link between transposon
regulation and TAR DNA-binding protein-43 (TDP-43), which
is one of the central players in the disease pathology (Li et al.,
2012).
TDP-43 is an aggregation prone protein that plays a key role in
a suite of neurodegenerative disorders (Cohen et al., 2011), in-
cluding amyotrophic lateral sclerosis (Lou Gehrig’s disease) and
frontotemporal lobar degeneration, which is the second leading
cause of dementia before the age of 65. TDP-43 is a multifunc-
tional RNA-binding protein with roles in many aspects of RNA
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regulation (Buratti and Baralle, 2010). Although it is not clear
how TDP-43 malfunction kills neurons, many downstream im-
pacts of TDP-43 proteinopathy have been elucidated. A series of
studies made use of deep sequencing to identify RNA targets of
TDP-43 in mouse, rat, and human neurons and characterized
changes in transcriptional profiles in response to genetic manip-
ulation of TDP-43 in mouse (Shan et al., 2010; Polymenidou et
al., 2011; Sephton et al., 2011; Tollervey et al., 2011). Together,
this literature identified thousands of RNA targets of TDP-43.
Typically, TDP-43 binds to a UG-rich motif in long intron-
containing transcripts. Many additional transcripts were found to
be mis-regulated in mouse models of TDP-43 proteinopathy. Be-
cause of the difficulty of mapping repetitive reads (Treangen and
Salzberg, 2012), each of these deep sequencing studies used anal-
yses that focused on single copy annotated genes and excluded
repetitive sequences, such as those that typically derive from
transposons. More recently, new algorithms for analyzing multi-
ple alignments of short sequence reads have been developed (Ji et
al., 2011; Li et al., 2012), permitting a systematic analysis of trans-
poson transcripts within these datasets. This analysis uncovered
extensive binding of TDP-43 to RNA sequences derived from
many transposons, including LINE, SINE, and LTR retrotrans-
posons (Li et al., 2012). In a dataset that compared TDP-43 tar-
gets from healthy control cortex and cortical tissue from
frontotemporal lobar degeneration patients (Tollervey et al.,
2011), the binding between TDP-43 and its transposon targets
was selectively and dramatically reduced (Li et al., 2012).Moreover,
examination of transposon sequences (Li et al., 2012) in RNA-seq
datasets from mice with disruptions of normal TDP-43 function
(Shanet al., 2010;Polymenidouet al., 2011) revealedupregulationof
many of the LINE, SINE, and LTR-retrotransposon transcripts to
which TDP-43 normally binds. Taken as awhole, thismeta-analysis
raises the possibility that TDP-43 normally plays a protective role by
binding to and silencing transposon transcripts.
The cellular mechanisms that lead to transposon activation in
the brain during aging and with some neurodegenerative disor-
ders are not understood. Furthermore, it is not known whether
transposon expression is a cause or a consequence of aging or of
neurodegenerative disease. Nevertheless, studies of dysfunctional
activation of transposons during aging and neurodegeneration
raise the provocative hypothesis that normally silenced trans-
posons can become “awakened” (i.e., unsilenced, leading to in-
creased expression andmobilization) in the brain during aging or
with disease.
Activation of transposable elements in an animal model of
PTSD and human alcoholism
There ismuch emerging evidence for the role of retrotransposons
in regulation of brain function in health and disease. The avail-
ability of whole-genome sequences of multiple species (Adams et
al., 2000; Lander et al., 2001; Waterston et al., 2002; Gibbs et al.,
2004; Nellaker et al., 2012) and recent genome-wide projects,
such as ENCODE (Dunhamet al., 2012), greatly accelerated these
research efforts, as information about the genomic location, di-
versity, and regulation of retrotransposons became available.
Studies that use whole-genome approaches (e.g., microarray
gene expression profiling and next-generation sequencing) can
benefit tremendously from these new data on the function and
localization of retrotransposons. A large portion of transcribed
sequences (transcripts) used by these technologies are “unanno-
tated” (i.e., corresponding to genomic locations with no protein-
coding genes or repeated sequences, such as ribosomal proteins
or retrotransposons).Most genomic studies usually discard these
sequences from the analysis and focus on a small number of
known protein-coding genes. An alternative is to take a systems
genomics approach, focusing on the regulation of the transcrip-
tome as a whole, including both coding and noncoding regions
(Oldham et al., 2008; Ward and Kellis, 2012). One of the first
coordinated efforts to investigate the role of TEs in the brain
using a genome-wide approach was the study of central mecha-
nisms underlying stress-enhanced fear learning (SEFL) in rats,
which is an accepted model of PTSD in humans (Rau and Fan-
selow, 2009; Ponomarev et al., 2010). PTSD is a brain disorder
that may develop after a person is exposed to one or more trau-
matic events. It is characterized by an exaggerated emotional re-
action to mild stressors, and people who have PTSD may feel
stressed or frightened even when they are no longer in danger. In
the SEFL model, rats preexposed to a severe stressor of 15 foot
shocks in one environment showed an enhanced freezing
response to a single “reminder” foot shock in a second environ-
ment (Rau et al., 2005). This SEFL is similar to the disproportion-
ately strong responses that PTSD patients show to reminders of
the stressor. Gene expression profiles in the amygdala of SEFL
rats were examined 3 weeks after the exposure to 15 foot shocks
using Illuminamicroarrays. Using a clustering algorithm, several
modules of genes coregulated by stress were detected, which cor-
responded to various functional and structural groups in the
brain, including genes coexpressed in neurons and astrocytes.
This finding suggested specific roles for these cell classes in the
development of SEFL (Ponomarev et al., 2010).
One surprising finding was a statistically distinctmodule con-
taining tightly coregulated transcripts with no annotations. Illu-
mina probesweremapped to the rat genomeusing a combination
of the UCSC Genome Browser and the RepeatMasker program
that identifies the location of genomic repeats, including retro-
transposons and showed that the majority of the unannotated
microarray probes mapped to multiple locations in the genome
that corresponded to LINE-1 retrotransposons. Furthermore, all
these transcripts were highly upregulated in the basolateral
amygdala of the SEFL rats compared with controls, suggesting
that a single stress exposure could result in a long-term activation
of retrotransposons. Retrotransposons are normally silenced by
epigenetic mechanisms, including DNA methylation and modi-
fications of histone tails, but can be expressedwhen the epigenetic
silencing is released (Slotkin and Martienssen, 2007). Therefore,
these results suggested that the increased expression of retro-
transposons in SEFL rats was the result of a “passive” release of
chromatin-mediated gene silencing. Interestingly, it was recently
shown that acute restraint stress in rats inhibited expression of
several classes of retrotransposons in the hippocampus through
increases in repressive histone H3 lysine 9 trimethylation
(Hunter et al., 2012). Therefore, there may be dynamic and op-
posing regulation of different types of retrotransposons depend-
ing on the magnitude and duration of the stressor as well as the
brain region where they are expressed.
In another recent study, gene expression profiling in postmor-
tem human brains of alcoholics and control cases using Illumina
microarrayswas conducted (Ponomarev et al., 2012). Alcoholism
is a serious health problem that causes a large economic and
disease burden (Grant et al., 2004; Rehm et al., 2009). Under-
standing the mechanistic changes in human brain after years of
alcohol abuse is critical to understanding the disease and devel-
oping therapeutics to fight it. Similar to the previous study
(Ponomarev et al., 2010), a systems genomics approach to tran-
scriptome profiling was conducted and generated a systematic
viewof brain alterations associatedwith alcohol abuse.One of the
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key components of this study was targeting differentially ex-
pressed retrotransposons in human alcoholic brain, including
the central and basolateral amygdala and superior frontal cortex.
Alignment of Illuminamicroarray probes to genomic retrotrans-
posons using the RepeatMasker program showed that nearly
4000 probes could be mapped to one of three classes of retro-
transposons (LINEs, SINEs, and LTRs) as well as DNA trans-
posons. Gene clustering revealed that probes representing at least
two TE classes (SINEs and LTR) were highly correlated (coregu-
lated) across samples, forming several distinct gene modules. In
addition, many probes mapped to several families of LTR-
containing TEs, and these LTR modules were upregulated in al-
coholics. Interestingly, the only Illumina probe corresponding to
a currently “active” LINE-1 family, L1HS (ILMN_2291619) was
also highly upregulated in alcoholic brain. Examination of DNA
methylation at the LTR regions showed that, in alcoholics, these
regions were less methylated, which is mechanistically consistent
with the activation of these transposons because they are sup-
pressed by methylation. This study showed that chronic alcohol
abuse resulted in DNA hypomethylation and transcriptional ac-
tivation of LTR-containing transposons and at least one family of
LINE-1 TE.
Stress enhances alcohol drinking in animal models, andmany
alcoholics have had stressful events associated with their alcohol
abuse (Becker et al., 2011; Sinha, 2012). Human alcoholism and
PTSD are comorbid conditions, as many PTSD patients abuse
alcohol (McCarthy and Petrakis, 2010). Based on the two studies
described above and other literature, it can be concluded that
stress and/or chronic alcohol may lead to transcriptional activa-
tion of TEs. Indeed, this is the first report suggesting that LTR-
containing TEs may play a functional role in alcoholism
(Ponomarev et al., 2012). These TEs represent a class of ERVs,
most of which are nonfunctional remnants of ancient retroviral
infections (Moyes et al., 2007). However, many human ERVs
have retained functional promoters and the potential to encode
viral proteins. Activation of ERVs has been linked to chronic
diseases, including cancer, multiple sclerosis, and autoimmune
disorders (Balada et al., 2009). An ERV-encoded glycoprotein,
syncytin, can directly activate microglia and astrocytes and pro-
duce neuroinflammation (Antony et al., 2004). Microglial acti-
vation can result in neuronal degeneration (Crews et al., 2011),
and compounds secreted by syncytin-activated astrocytes can
produce cytotoxicity to oligodendrocytes and myelin degenera-
tion (Antony et al., 2004), which is consistent with pathologies
observed in alcoholics (Harper et al., 2003; Pfefferbaum et al.,
2009; Zahr et al., 2011). Based on recent evidence that alcohol-
induced neuroimmune responses are critical factors in alcohol
addiction (Crews et al., 2011), these studies propose a potential
role for ERVs in neuroinflammation and brain pathophysiology
of human alcoholism. However, it remains to be determined
whether ERVs play a causal role because it is not known whether
altered expression of ERVs results in the expression of viral pro-
teins and the initiation of the immune response in brain.
In addition to understanding the functional role of TEs in
brain function, utilization of the emerging knowledge about the
epigenetic regulation of TEs will enable a complete picture of TE
regulation and function (Xie et al., 2013). TEs are tightly con-
trolled and silenced by epigenetic mechanisms, and their expres-
sion patterns can be used as markers of epigenetic modifications
without directly measuring epigenetic marks. Furthermore, de-
tecting certain epigenetic changes may lead to hypotheses about
TE regulation. There is substantial evidence suggesting the im-
portance of epigenetics in stress-related disorders, including
PTSD and alcoholism (Radley et al., 2011; Robison and Nestler,
2011), and this knowledge may be useful in better understanding
the role of TEs in these conditions. In addition, many epigenetic
therapeutics have been developed for non-CNS diseases. There-
fore, epigenetic mechanisms could be targeted to alter the poten-
tially deleterious effects of brain retrotransposons. Finally,
examination of the effects of stress and alcohol on retrotrans-
posons in additional regions of the brain is warranted. In partic-
ular, the hippocampus is an important target of stress and
alcohol; both stress and alcohol decrease adult hippocampal neu-
rogenesis (Dranovsky andHen, 2006;Nixon, 2006). Themajority
of studies examining the function and expression of retrotrans-
posons have been conducted in this region because neurogenesis
in the hippocampus has been shown to substantially regulate the
activity of retrotransposons (Muotri et al., 2005, 2009; Coufal et
al., 2009; Muotri et al., 2010; Baillie et al., 2011).
Conclusions and future directions
The longstanding idea that neuronal genomes contain stable, un-
changing DNA is now being challenged by mounting evidence
that somatic retrotransposition occurs in neurons. This review
has highlighted the evidence that retrotransposons,McClintock’s
“jumping genes,” must now be considered as a viable source of
genetic variability in the brain and in health and disease of the
CNS. The advances in genomic technologies have enabled a
deeper understanding of the role of retrotransposons in neuronal
function and evolution. This is indeed an exciting time for what
was once dismissed as genomic “parasites” or “selfish” entities of
the genome.
The sheer abundance of retrotransposons in eukaroyotic ge-
nomes begs us to reconsider their role in biology and in neuro-
science in particular. Altered retrotransposon expression or
function appears to be associated with stress, alcohol, neurode-
generation, and aging. However, we need to better define the
functional consequences of these retrotransposons, which could
lead to novel treatment strategies for a multitude of psychiatric
and neurological disorders.
Finally, the evolutionary significance of retrotransposons,
especially in the evolution of brain function, is paramount in
understanding why nature has produced such a biological mech-
anism. Cross-species analysis of the function of retrotransposons
in the brain will undoubtedly provide clues to their origin and
their potential as drivers of genomic innovation.
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